Masimo Corporation (LON:0JZ2)
London · Delayed Price · Currency is GBP · Price in USD 144.98
+4.43 (3.15%)
At close: Nov 7, 2025
Masimo Market Cap
Masimo has a market cap or net worth of 5.84 billion as of November 7, 2025. Its market cap has decreased by -0.46% in one year.
Market Cap
5.84B
Enterprise Value
6.05B
Revenue
1.63B
Ranking
n/a
PE Ratio
n/a
Stock Price
144.98
Market Cap Chart
Since August 8, 2007, Masimo's market cap has increased from 541.95M to 5.84B, an increase of 977.69%. That is a compound annual growth rate of 13.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 5.84B | -17.38% |
| Dec 31, 2024 | 7.07B | 45.39% |
| Dec 29, 2023 | 4.86B | -24.67% |
| Dec 30, 2022 | 6.45B | -45.94% |
| Dec 31, 2021 | 11.94B | 10.33% |
| Dec 31, 2020 | 10.82B | 69.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.04B |
| GSK plc | 71.07B |
| Haleon | 32.17B |
| Smith & Nephew | 10.74B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.50B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.58B |